Get access
Clinical Endocrinology

Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers

Authors


Birgitte Andersen, Niels Steensensvej 4, 2820 Gentofte, Denmark. Tel.: +45 4443 4333; Fax: +45 44438000; E-mail: BttA@hagedorn.dk

Summary

Objective  Fibroblast growth factor (FGF21) is a potent regulator of glucose and lipid metabolism. In rodents, the hepatic expression of FGF21 is controlled by fasting and a circadian regulation, but the physiological role and regulation of FGF21 in humans is not well established. Therefore, the objective of this study was to elucidate the 24-h profiling of plasma FGF21 during a 72-h fast.

Study design  After an initial 12-h overnight fast, plasma levels of FGF21 together with circulating levels of glucose, insulin, glucagon and free fatty acids (FFA) were measured every 6 h during a 72-h fast in healthy female volunteers (n = 14).

Results  During the fast, plasma glucose and serum insulin gradually decreased whilst glucagon and FFA levels increased. Mean 24-h plasma FGF21 levels did not increase during the 72-h fast, but, despite large inter-individually variations, a significant circadian rhythm was observed. Thus, during the first day, plasma FGF21 increased from 125 pg/ml (16–142) at 8.30 a.m to peak levels of 224 pg/ml (88–326) at 2.30 a.m (P = 0·0215), the second day from 60 pg/ml (7–74) at 8.30 a.m to 268 pg/ml (103–410) at 2.30 a.m. (P = 0·0010) and the third day from 94 pg/ml (9–146) to 151 pg/ml (87–207) at 2.30 a.m. (P = 0·0049). Cortisol also showed circadian regulation and peaked at 8.30 a.m every day, 6 h after the observed FGF21 peak.

Conclusion  Plasma FGF21 follows a circadian rhythm during a 72-h fast in healthy female subjects. The circadian regulation has a stronger impact on plasma FGF21 than the fasting status over 72-h period.

Get access to the full text of this article

Ancillary